Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany

Risk Management and Healthcare Policy

Volumn 11, Issue , 2018, Pages 77-82

  Froessler, Bernd ^a,b   Rueger, Alexandra M ^c,d   Connolly, Mark P ^e,f  

^a LYELL MCEWIN HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Vifor (International) Inc   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f St Prex   (Switzerland)

Author keywords

Anemia; Blood transfusion; Economic evaluation; Intravenous iron; Iron deficiency; Patient blood management

Indexed keywords

FERRIC CARBOXYMALTOSE;

ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMIC ASPECT; ELECTIVE SURGERY; GERMANY; HOSPITALIZATION; HUMAN; IRON DEFICIENCY ANEMIA; LENGTH OF STAY; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; SENSITIVITY ANALYSIS;

EID: 85064646821     PISSN: None     EISSN: 11791594     Source Type: Journal    
DOI: 10.2147/RMHP.S157379     Document Type: Article

References (20)

1. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth. 2011;106(1):13–22.
2. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378(9800):1396–1407.
3. Hreinsson JP, Jonasson JG, Bjornsson ES. Bleeding-related symptoms in colorectal cancer: a 4-year nationwide population-based study. Aliment Pharmacol Ther. 2013;39(1):77–84.
4. Hönemann C, Bierbaum M, Heidler J, Doll D, Schöffski O. [Kosten der Verabreichung von Blutkonserven im Krankenhaus]. Chirurg. 2013;84(5):426–432. German
5. Ludlam CA, Powderly WG, Bozzette S, et al. Clinical perspectives of emerging pathogens in bleeding disorders. Lancet. 2006;367(9506):252–261.
6. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009;108(3):759–769.
7. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery. Ann Surg. 2012;256(2):235–244.
8. Kleineruschkamp AG, Zacharowski K, Ettwein C, et al. [Cost analysis of patient blood management]. Anaesthesist. 2016;65(6):438–448. German
9. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50(4):753–765.
10. Glenngard AH, Persson U, Soderman C. Costs associated with blood transfusions in Sweden-the societal cost of autologous, allogeneic and perioperative RBC transfusion. Transfus Med. 2005;15(4):295–306.
11. Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–1358.
12. Goodnough LT, Shander A. Blood management. Arch Pathol Lab Med. 2007;131(5):695–701.
13. Leal-Noval SR, Munoz M, Asuero M, et al; Spanish Expert Panel on Alternatives to Allogeneic Blood Transfusion. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the “Seville Document”. Blood Transfus. 2013;11(4):585–610.
14. Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood transfus. 2014;12(3):296–300.
15. Froessler B, Dekker G, McAuliffe G. To the rescue: the role of intravenous iron in the management of severe anaemia in the peri-partum setting. Blood transfus. 2015;13(1):150–152.
16. Munoz M, Gomez-Ramirez S, Campos A, Ruiz J, Liumbruno GM. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus. 2015;13(3):370–379.
17. Munoz M, Gomez-Ramirez S, Liumbruno GM, Grazzini G. Intravenous iron and safety: is the end of the debate on the horizon? Blood transfus. 2014;12(3):287–289.
18. Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery. Ann Surg. 2016;264(1):41–46.
19. LauerTaxe. 2016. Available from: https://www.cgm.com/lauer-fischer/loesungen_lf/lauer_taxe_lf/lauer_taxe_en.de.jsp. Accessed December 10, 2017.
20. Luporsi E, Mahi L, Morre C, Wernli J, de Pouvourville G, Bugat R. Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective. J Med Econ. 2011;15(2):225–232.